BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/5/2026 9:11:01 AM | Browse: 9 | Download: 2
Publication Name World Journal of Stem Cells
Manuscript ID 127499
DOI 10.4252/wjsc.127499
Country China
Category Obstetrics & Gynecology
Manuscript Type Minireviews
Article Title Stem cell-based therapy for premature ovarian insufficiency: From mechanisms to clinical translation
Manuscript Source Unsolicited Manuscript
All Author List Li-Chun Weng, Shu-Ping Lyu and Hai-Yan Peng
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82301854, 82603233
Youth Clinical Research Program of the Shanghai Municipal Health Commission 20264Y0163
Fundamental Research Funds for the Central Universities YG2026QNA50
Corresponding Author Shu-Ping Lyu, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China. lv0217shuping@163.com
Key Words Premature ovarian insufficiency; Stem cell therapy; Mesenchymal stem cells; Ovarian regeneration; Clinical studies
Core Tip Premature ovarian insufficiency, characterized by ovarian dysfunction before age 40, causes infertility, menopausal symptoms, and long-term health risks, while hormonal therapy does not restore ovarian reserve or fertility. Stem cell-based therapies show regenerative potential, particularly mesenchymal stem/stromal cells and extracellular vesicles, through anti-apoptotic, antioxidant, angiogenic, immunomodulatory, and paracrine effects. Emerging gene-modified cells and cell-free products may enhance therapeutic precision and translational feasibility. However, clinical evidence remains limited and heterogeneous. Future progress requires mechanism-guided optimization, standardized manufacturing and potency assessment, appropriate delivery strategies, and rigorously designed randomized controlled trials to establish long-term safety and efficacy.
Citation Weng LC, Lyu SP, Peng HY. Stem cell-based therapy for premature ovarian insufficiency: From mechanisms to clinical translation. World J Stem Cells 2026; In press
PDF 127499-in-press.pdf
Received
2026-08-31 07:16
Peer-Review Started
2026-08-31 07:16
First Decision by Editorial Office Director
Return for Revision
2026-09-08 03:14
Revised
2026-09-22 08:36
Publication Fee Transferred
2026-10-21 10:54
Second Decision by Editor
2026-10-23 11:31
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-05 09:11
Articles in Press
2026-11-05 09:11
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com